Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.9 |
mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.055 | 0.9 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.9 |
mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |